
Statements May 27, 2025
IMC Responds to the Speech from the Throne
Ottawa, May 27, 2025 – Today, His Majesty King Charles III delivered the Speech from the Throne, outlining the federal […]
Our news library that includes all press releases and industry related news.
Statements May 27, 2025
Ottawa, May 27, 2025 – Today, His Majesty King Charles III delivered the Speech from the Throne, outlining the federal […]
In the news May 14, 2025
Ensuring Pharmacare delivers fair access for all and innovation As originally published in The Hill Times Policy Briefing on May […]
In the news October 08, 2024
As originally published on the Health Insight website here, October 2024. Authored by: Dr. Bettina Hamelin President, Innovative Medicines Canada Canada is […]
In the news October 07, 2024
As originally published on the Canadian Science Policy Centre website here, October 2024. Authored by: Dr. Bettina Hamelin President, Innovative Medicines […]
In the news September 18, 2024
As originally published in The Hill Times on September 18, 2024. Focus on embracing the rapid pace of scientific discovery, […]
In the news July 12, 2024
This article originally appeared in Saltwire newspapers across Atlantic Canada on July 11, 2024. Dr. P.J. Devereaux, co-chair of Accelerating Clinical Trials […]
In the news March 04, 2024
This article originally appeared in the The Globe and Mail on March 4, 2024. Strong gender representation in workplace leadership helps businesses […]
In the news February 28, 2024
Further delays risk undermining the health and well-being of the very patients the National Strategy for Drugs for Rare Diseases was intended to assist.
In the news February 26, 2024
This article originally appeared in the Hill Times on February 13, 2024. After a diagnosis, having access to state-of-the-art medicines or treatments […]
In the news October 03, 2023
This article originally appeared in the Toronto Star on September 30, 2023. Long wait times for new medicines in Canada, averaging two […]
In the news September 21, 2023
A recent report by the Patented Medicine Prices Review Board shows increased growth for private drug plan costs but promising pharmaceutical innovation, says Joe Farago, executive director of private payers and investment at Innovative Medicines Canada.
In the news September 05, 2023
This article originally appeared in the Benefits and Pensions Monitor on September 5, 2023. ‘If the insurance industry doesn’t upgrade drug insurance […]
Informative content to keep you up to date on the most pressing issues facing our industry.